Ausgewählte Studien

J Dtsch Dermatol Ges. 2021 Jun;19(6):934-150. doi: 10.1111/ddg.14508. NO ABSTRACT PMID:34139083 | DOI:10.1111/ddg.14508 Den ganzen Artikel lesen

J Dtsch Dermatol Ges. 2021 Jun;19(6):934-951. doi: 10.1111/ddg.14508_g. NO ABSTRACT PMID:34139080 | DOI:10.1111/ddg.14508_g Den ganzen Artikel lesen

Hautarzt. 2021 Jul;72(7):570-577. doi: 10.1007/s00105-021-04832-2. Epub 2021 Jun 16. ABSTRACT BACKGROUND: The skin is an organ frequently affected by chronic diseases. Inflammatory, immune-mediated dermatoses such as atopic dermatitis and psoriasis show a high prevalence as well as a significant impact on the quality of life of those affected. In a large proportion of cases, atopic dermatitis is associated with a marked change in microbial colonization of both clinically healthy and affected ski

Hautarzt. 2021 Jun 16. doi: 10.1007/s00105-021-04833-1. Online ahead of print. ABSTRACT BACKGROUND: Guidelines generally recommend an adjuvant treatment with emollients for patients suffering from psoriasis. However evidence for this purpose is limited. PATIENTS AND METHODS: We performed a prospective observational study with an emollient containing 10% urea, ceramides, glycerin and glyceryl glucoside in patients suffering from mild to moderate psoriasis. The patients had to be stable for at lea

Hautarzt. 2021 Jul;72(7):579-585. doi: 10.1007/s00105-021-04830-4. Epub 2021 Jun 11. ABSTRACT BACKGROUND: Our skin is a very important and complex organ of the body. The microorganisms of the skin, the so-called microbiome, represent an important part of the healthy skin barrier and are influenced by various external and internal factors. AIM: The question to what extent the skin microbiome represents a diagnostic or even therapeutic target in the context of skin diseases is discussed. MATERIALS

Clin Epidemiol. 2021 May 26;13:373-382. doi: 10.2147/CLEP.S304155. eCollection 2021. ABSTRACT BACKGROUND: Most epidemiological data on vitiligo refer to selected environments or focus on the prevalence of comorbidity unrelated to the population. OBJECTIVE: Aim of the study was to gain robust representative prevalence data on vitiligo and on associated dermatologic comorbidity in the German adult population. METHODS: A dual population-based approach was applied with 1) primary data obtained betwe

Br J Dermatol. 2021 Jun 2. doi: 10.1111/bjd.20527. Online ahead of print. ABSTRACT Eczema and eczematous reactions induced by interleukin (IL)-17 inhibitors in patients with psoriasis are established adverse events (1), which may be reported as adverse events (AEs) in up to 12.1% patients on anti-IL-17 treatment in controlled clinical trials (2-5). We performed an integrated safety analysis of 13 clinical studies to evaluate the frequency and management of the treatment-emergent adverse events (

Nutrients. 2021 May 31;13(6):1897. doi: 10.3390/nu13061897. ABSTRACT BACKGROUND: Psoriasis is a systemic inflammatory disorder, primarily characterized by skin plaques. It is linked to co-morbidities including cardiovascular disease and metabolic syndrome. Several studies demonstrate that dietary habits can influence psoriasis development and severity. However, the effect of different dietary protein levels on psoriasis development and severity is poorly understood. In this study, we examine the

J Eur Acad Dermatol Venereol. 2021 May 31. doi: 10.1111/jdv.17427. Online ahead of print. ABSTRACT In the context of the current coronavirus disease 2019 (COVID-19) pandemic, there is no direct evidence to support any preferred biologic therapy for psoriasis. However, known safety profile of different classes of biologic therapies as well as individual risk factors for infections must be considered. Here, we report incidence rates of respiratory or viral infections through 5 years among patients

Actas Dermosifiliogr. 2020 Nov;111(9):802-804. doi: 10.1016/j.adengl.2020.05.001. Epub 2020 Oct 16. NO ABSTRACT PMID:34012158 | PMC:PMC7566662 | DOI:10.1016/j.adengl.2020.05.001 Den ganzen Artikel lesen